Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Hub.
Press releases published on August 12, 2025
Automotive Natural Gas Vehicle Market Projected to USD 21.6 Billion, with a CAGR of 5.18% by 2032
EIN Presswire
·
August 12, 2025
Valued at USD 13.6 Billion in 2023, the market is projected to reach USD 21.6 Billion by 2032, supported by the shift towards cleaner fuel alternatives. NEW YORK, NY, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- As per MRFR Analysis, the …
Fair Oaks Farms Announces 2025 Harvest Season
EIN Presswire
·
August 12, 2025
Apple picking, pumpkin festivals, and family farm fun await visitors from August through November FAIR OAKS, IN, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Fair Oaks Farms invites families to celebrate harvest season with apple, pumpkin and …
HANDL Joins List of Elite Brand Partners Helping To Launch the 'tm:rw Experience'
EIN Presswire
·
August 12, 2025
Famed Artist Allen Hirsch Offers Unique Phone Grips That Are Both Functional and Artistic; Developing Commemorative Product Line to Mark tm:rw Grand Opening NEW YORK, NY, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- tm:rw, a new “multi-sensory …
Erdene Announces Q2 2025 Results
GlobeNewswire
·
August 12, 2025
HALIFAX, Nova Scotia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) ("Erdene" or the "Company") is pleased to announce operating and financial results for the three months ended June 30, 2025, and to …
Tranquil Tails Launches PET ZEN Calming Spray for Dogs and Cats at SUPERZOO 2025
EIN Presswire
·
August 12, 2025
A companion to the brand’s diffuser system, delivering calming pheromone technology for dogs and cats LAS VEGAS, NV, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- At SUPERZOO 2025, North America’s largest pet industry trade show, Tranquil Tails …
Primadonna Armchair by Ariane Rosa Wins Bronze in A' Design Award for Furniture Design
EIN Presswire
·
August 12, 2025
Ariane Rosa's Primadonna Armchair Recognized for Exceptional Design and Craftsmanship in Prestigious International Competition COMO, CO, ITALY, August 12, 2025 /EINPresswire.com/ -- The A' Design Award, a highly respected recognition in the field of …
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
August 12, 2025
Received FDA feedback on Pre-IND Briefing Document reinforcing Company’s intention to advance investigational new drug (IND) submission for CUE-401 to address unmet need in the treatment of autoimmune disease. Announced strategic research collaboration and …
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
– Multiple near-term potential milestones, including anticipated completion of primary structure analysis and select functional analyses in 3Q’25 – – Type 2a meeting with the FDA anticipated in 4Q’25– – Cash runway expected to support operations through …
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 2025 – Phase 2 ASPEN-Breast evorpacept trial design …
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
GlobeNewswire
·
August 12, 2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of LYL314 in patients with large B-cell …
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
- Positive IDMC Recommendation to Continue Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in AML Without Modification; Final Analysis Anticipated by Year-end 2025 – - Reported Positive Phase 2 Results of SLS009 in Relapsed/Refractory (r/r) Acute …
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T cell- …
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 12, 2025
Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025 Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline …
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) and BLA submission anticipated in 1H 2026 Registrational Phase 3 KYV-101 trial in myasthenia gravis (MG) to include ~60 patients with enrollment to initiate by year-end …
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
GlobeNewswire
·
August 12, 2025
MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) Expected in Q3 2025 MZE829 Phase 2 HORIZON Trial Actively Enrolling Patients with APOL1-Mediated Kidney Disease; …
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 12, 2025
First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free conditioning for severe lupus nephritis demonstrated durability of response with drug-free definition of remission in systemic lupus erythematosus (DORIS …
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
GlobeNewswire
·
August 12, 2025
PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC) Spero, along with its development partner, GSK, plans to …
Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock
GlobeNewswire
·
August 12, 2025
Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% …
Game Changer PanteraPay Launches 'All-Inclusive' Smart Billing Payment Solution for Small Businesses
EIN Presswire
·
August 12, 2025
PanteraPay is a smart billing and payment platform designed to help small businesses take control of their cash flow. ORLANDO, FL, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- PanteraPay, the innovative online and mobile-based billing and …
Nasal Packing Device Market Poised for Significant Growth, Projected to Reach 6.13 (USD Billion) by 2034
EIN Presswire
·
August 12, 2025
The market is intricately segmented to cater to a diverse range of medical needs and preferences. NEW YORK, NY, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- As per MRFR analysis, the Nasal Packing Device Market Size was estimated at 3.75 (USD …